Universiti Malaya Affordable Diagnostics and Therapeutics (UMADT)

An academic platform fostering quadruple helix partnerships to drive technology, product, and policy development for affordable healthcare solutions. UMADT is Southeast Asia’s interdisciplinary hub dedicated to bridging healthcare gaps in low-resource settings. As a flagship initiative under International Affordable Diagnostics & Therapeutics Alliance (IA-DATA), we unite clinicians, scientists, policymakers, and industry leaders to advance affordable diagnostics and drug repurposing, establishing Malaysia as a leader in accessible medical solutions for ASEAN, IsDB-linked countries, and the global South. Through cutting-edge research, ethical clinical trials, and strategic partnerships, UMADT focuses on drug repurposing to identify evidence-based, cost-effective treatments for cancer, infectious diseases, and inflammatory disorders. By optimizing existing medications for new therapeutic uses, we accelerate access to safe, scalable healthcare solutions for underserved populations. Collaborating with government agencies, research institutions, CROs, pharmaceutical companies, and industry players, UMADT provides a clinical validation ecosystem that ensures safety, efficacy, and market accessibility. Our work supports policy development, knowledge transfer, and funding partnerships, making Malaysia a global center for affordable medicine and diagnostics. Join us as we redefine equitable healthcare, fostering sustainable innovation and lifesaving medical solutions for the next generation.